Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043439 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jihye Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Animal Medicine, College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea. Hauptthemen laut MEDLINE: Inflammasomes, Thymosin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean government.
Abstract (Originalsprache)
Risk signals are characteristic of many common inflammatory diseases and can function to activate nucleotide-binding oligomerization (NLR) family pyrin domain-containing 3 (NLRP3), the innate immune signal receptor in cytoplasm. The NLRP3 inflammasome plays an important role in the development of liver fibrosis. Activated NLRP3 nucleates the assembly of inflammasomes, leading to the secretion of interleukin (IL)-1β and IL-18, the activation of caspase-1, and the initiation of the inflammatory process. Therefore, it is essential to inhibit the activation of the NLRP3 inflammasome, which plays a vital role in the immune response and in initiating inflammation. RAW 264.7 and LX-2 cells were primed with lipopolysaccharide (LPS) for 4 h and subsequently stimulated for 30 min with 5 mM of adenosine 5′-triphosphate (ATP) to activate the NLRP3 inflammasome. Thymosin beta 4 (Tβ4) was supplemented to RAW264.7 and LX-2 cells 30 min before ATP was added. As a result, we investigated the effects of Tβ4 on the NLRP3 inflammasome. Tβ4 prevented LPS-induced NLRP3 priming by inhibiting NF-kB and JNK/p38 MAPK expression and the LPS and ATP-induced production of reactive oxygen species. Moreover, Tβ4 induced autophagy by controlling autophagy markers (LC3A/B and p62) through the inhibition of the PI3K/AKT/mTOR pathway. LPS combined with ATP significantly increased thee protein expression of inflammatory mediators and NLRP3 inflammasome markers. These events were remarkably suppressed by Tβ4. In conclusion, Tβ4 attenuated NLRP3 inflammasomes by inhibiting NLRP3 inflammasome-related proteins (NLRP3, ASC, IL-1β, and caspase-1). Our results indicate that Tβ4 attenuated the NLRP3 inflammasome through multiple signaling pathway regulations in macrophage and hepatic stellate cells. Therefore, based on the above findings, it is hypothesized that Tβ4 could be a potential inflammatory therapeutic agent targeting the NLRP3 inflammasome in hepatic fibrosis regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Animal Medicine, College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea.
ORCID-Profile: Jihye Choi
Förderung
- Korean government
Zitieren
APA
Choi, J., Cho, Y., Choi, H., Lee, S., Han, H., Lee, J., & Kwon, J. (2023). Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043439
Vancouver
Choi J, Cho Y, Choi H, Lee S, Han H, Lee J, et al. Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043439
BibTeX
@article{Choi2023,
author = {Choi, Jihye and Cho, Yunsang and Choi, Hwal and Lee, Sangmin and Han, Hyeju and Lee, Jeonghyeon and Kwon, Jungkee},
title = {Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043439}
}
EUVIMED